key: cord-0809822-6ktpk7le
authors: Vilhena, Fabiano Vieira; Orcina, Bernardo da Fonseca; Reia, Verônica Caroline Brito; Zangrando, Mariana Ragghianti; de Oliveira, Rodrigo Cardoso; Santos, Paulo Sérgio da Silva
title: Importance of oral health care in times of COVID-19
date: 2021-12-03
journal: Einstein (Sao Paulo)
DOI: 10.31744/einstein_journal/2021ce6706
sha: 185b48e8e54c59b6e31e8b11b9df22540e9b88e8
doc_id: 809822
cord_uid: 6ktpk7le

nan

Dear Editor, The infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the host cells occurs by interaction of cleaved viral protein spike with the receptors of angiotensin-converting enzyme 2 (ACE2) and of transmembrane serine protease 2 (TMPRSS2). The presence of ACE2 and TMPRSS2 in the salivary glands make them a reservoir for SARS-CoV-2, leading to cell endocytosis and the viral replication cycle. This knowledge is relevant to better understand and develop strategies to mitigate contamination by droplets. (1) Since the oral cavity is closely related to the progression of the coronavirus 2019 disease (COVID-19), and the oral health status is associated to severity of the condition, (2) adopting preventive measures, such as maintenance of oral health by chemical-mechanical control of oral microbiota, becomes a relevant issue. (3) (4) (5) (6) The medical literature has shown the use of broad-spectrum antiseptic mouthwashes demonstrated laboratory results and clinical efficacy in reducing the viral load and symptoms of COVID-19 (3) (4) (5) (6) (Table 1 ). The evidence is as recent as the pandemic.

Therefore, it seems maintenance of oral health, with the correct strategies, does not lead to contraindications or evidence of non-effectiveness in prevention of COVID-19. Table 1 . List of antiseptic mouthwashes used and their respective benefits in treating COVID-19 patients

Povidone-iodine (PVP-I) (3) Reducing viral load Chlorhexidine (3) Reducing viral load ß-cyclodextrin/Citrox (4) Reducing viral load Hydrogen peroxide (3) Reducing viral load Anionic phthalocyanine derivative (APD) -(Phtalox ® ) (5, 6) Reducing viral load, reducing symptoms, reducing severity of disease, reducing length of hospital stay 

Salivary glands are a target for SARS-CoV-2: a source for saliva contamination

The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values

Oral antiseptics against coronavirus: in vitro and clinical evidence

Use of an antiviral mouthwash as an additional barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicenter, randomized, double-blind controlled trial

A phthalocyanine derivate mouthwash to gargling/rinsing as an option to reduce Clinical Symptoms of COVID-19: case series

Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial